Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
65.40    -0.60 (-0.91%)
Bid:
65.60
Ask:
70.00
Spread: 4.40 (6.707%)
Market Cap: £88.27m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Trading Statement

18 Sep 2008 07:00

RNS Number : 7096D
Trifast PLC
18 September 2008
 

18 September 2008

TRIFAST PLC ('Trifast' or 'the Company' or 'the Group')

TRADING UPDATE

Trifast, a worldwide manufacturer and distributor of industrial fasteners and components, today provides an update on recent trading.

As the Company indicated in its last Interim Management Statement, Trifast had a satisfactory start to the financial year and trading was broadly in line with market expectations for the first quarter to 30 June 2008. However, whilst July's results were in line with internal budgets, the trading performance of the Group since then has been extremely disappointing. There have been a number of factors responsible for this. Demand from customers in the UK and Europe has been lower than anticipated and a number of projects that we were due to be supplying product to have been postponed. In the Far East we have seen a major reduction in the supply of fastener components to one customer in the computer industry, causing an additional impact on margin due to the under-utilised capacity in our production facilities in Asia In addition, in Europe and Asia we have experienced a slowing of demand from customers in the automotive industries. 

By contrast, sales activity levels across the Group remain high and future business and new customers are being won at an encouraging level, which will benefit the Group in the next financial year. In addition, our business in the United States has performed well, albeit that it is small in relation to the Group's overall operations.

In current market conditions it is too early to forecast with any certainty prospects for the financial year as a whole. However, the declining and postponed sales orders experienced to date are unlikely to be recovered in the second half of the year and consequently the Board expects that the outcome for the year to 31 March 2009 is likely to be well below current market expectations.

Although efforts are being made to boost sales orders, the financial impact of the factors described above on an annualised basis, when compared with the profit before taxation (before intangible amortisation, IFRS2 charges and impairment of associated company) for the year ended 31 March 2008 of £8.8 million, is likely to be as follows: a reduction in the order of £1 million for the lost contract in the Far East, a reduction of a similar amount for slower sales volumes in Europe, and a reduction of £0.6 million to reflect the higher fuel, energy and freight costs being incurred by the Group.

Overall the Board remains cautiously optimistic with regards to Trifast's medium and long term prospects. The Group has a strong balance sheet with low gearinggood operational cash generation and a broad and growing base of international customers in diverse industry sectors - strengths that will help the Company during the current demanding trading conditions.

ENDS -

Enquiries

Trifast Group plc Tel: 01825 747 366

Steve Auld, Chief Executive Officer

Stuart Lawson, Chief Financial Officer

Smithfield Consultants

Reg Hoare / Will Swan Tel: 020 7360 4900

Fairfax I.S. plc

Simon Bennett / Jeremy Porter Tel: 020 7598 5368

For more information please visit www.trifast.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGUUUCBUPRGBM
Date   Source Headline
21st Nov 20243:09 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSHALF-YEARLY FINANCIAL REPORT
22nd Oct 20247:00 amRNSTrading update and Notice of Half-year results
12th Sep 20244:21 pmRNSDirector/PDMR Shareholding
10th Sep 20244:48 pmRNSResult of AGM
10th Sep 20247:01 amRNSAGM Statement
10th Sep 20247:00 amRNSAppointment of CFO
27th Aug 20249:21 amRNSProposed new Directors Remuneration Policy
21st Aug 20249:32 amRNSDirector/PDMR Shareholding
15th Aug 202411:40 amRNSHolding(s) in Company
6th Aug 20243:49 pmRNSPurchase of shares
31st Jul 20244:00 pmRNSAvailability of Annual Report & Notice of Meeting
29th Jul 20247:00 amRNSAnnual Results - 31 March 2024 - Annual Report
23rd Jul 20247:00 amRNSFY24 annual results - date confirmation
2nd Jul 20244:43 pmRNSFY24 results publication–revision of release date
11th Jun 20249:24 amRNSAnnual results presentations
25th Apr 20247:00 amRNSTrading update & Notice of Annual results
15th Apr 20242:11 pmRNSDirector/PDMR Shareholding
15th Apr 20241:07 pmRNSDirector/PDMR Shareholding
4th Apr 202410:40 amRNSBlock listing Interim Review
21st Mar 20247:00 amRNSDirector/PDMR Shareholding - Purchase of shares
13th Mar 20242:30 pmRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSAppointment & retirement of non-executive director
22nd Feb 20247:00 amRNSDirectorate Change
9th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 202410:09 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 20249:33 amRNSHolding(s) in Company
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 202411:23 amRNSDirector/PDMR Shareholding
22nd Jan 20243:20 pmRNSDirector/PDMR Shareholding
22nd Jan 20247:00 amRNSTrading Update
3rd Jan 20245:50 pmRNSTotal Voting Rights
21st Dec 20234:24 pmRNSHolding(s) in Company
21st Dec 20234:18 pmRNSHolding(s) in Company
15th Dec 20237:00 amRNSNon executive director retirement update
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSPDMR - Performance conditions for LTIP award
24th Nov 20232:34 pmRNSDirector/PDMR shareholding - Purchase of shares
21st Nov 20237:00 amRNSHalf-year Report - six months to 30 September 2023
24th Oct 20237:00 amRNSHalf year trading update and notice of results
19th Oct 20237:00 amRNSNon-executive Director appointment
12th Oct 20237:00 amRNSDirectorate retirement
3rd Oct 20234:16 pmRNSBlock listing Interim Review
25th Sep 20233:49 pmRNSHolding(s) in Company
19th Sep 20234:45 pmRNSPDMR Save As You Earn Plan grant of Option
15th Sep 20233:05 pmRNSResult of AGM
15th Sep 20239:15 amRNSCEO appointment
14th Sep 20234:48 pmRNSDirectorate Change
29th Aug 20237:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.